Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy
对不适合接受强化化疗的急性髓系白血病患者进行低剂量阿糖胞苷和维奈托克治疗的风险分层
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025017083
Wei, Andrew H; Panayiotidis, Panayiotis; Montesinos, Pau; Laribi, Kamel; Ivanov, Vladimir; Kim, Inho; Novak, Jan; Champion, Rebecca; Fiedler, Walter; Pagoni, Maria; Bergeron, Julie; Ting, Stephen B; Hou, Jing-Zhou; Yamauchi, Takahiro; Wang, Jianxiang; Strickland, Stephen A; Savona, Michael R; Lin, Tara L; Enjeti, Anoop; Tiong, Ing Soo; Lee, Sangmin; Roboz, Gail J; Popovic, Relja; Jiang, Qi; Liu, Zihuan; Sun, Yan; Mendes, Wellington; Chyla, Brenda; DiNardo, Courtney D